Tarlatamab is an investigational medication being studied for treating small-cell lung cancer. It is a new type of targeted therapy designed to fight cancer cells.

Durvalumab is an immunotherapy medication that helps the body’s immune system fight cancer cells. It works by blocking certain proteins that cancer cells use to hide from the immune system.

Carboplatin is a chemotherapy medication that works by interfering with cancer cell growth and division. It is commonly used to treat various types of cancer, including lung cancer.

Etoposide is also a chemotherapy medication that works by stopping cancer cells from growing and dividing. It is often used in combination with other cancer treatments, particularly in treating lung cancer.

Small-cell lung cancer – An aggressive type of lung cancer that develops from neuroendocrine cells in the lungs. It is strongly linked to smoking and represents 10-15% of all lung cancer cases. The disease is characterized by rapid growth and quick spread throughout the body. In extensive stage small-cell lung cancer, the cancer has already spread beyond the original location to distant parts of the body or is too large in size. This form of cancer grows much faster than many other types of lung cancer, with tumor cells multiplying rapidly. The extensive stage of this disease is the most common presentation, occurring in about 70% of patients at the time of diagnosis.